Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.

Autor: Altekruse SF; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, United States of America., Petrick JL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America., Rolin AI; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, United States of America., Cuccinelli JE; Information Management Services, Inc., Calverton, MD, United States of America., Zou Z; Information Management Services, Inc., Calverton, MD, United States of America., Tatalovich Z; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, United States of America., McGlynn KA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.

Publikováno v: PloS one [PLoS One] 2015 Apr 02; Vol. 10 (3), pp. e0120574. Date of Electronic Publication: 2015 Apr 02 (Print Publication: 2015).

The role of living donor liver transplantation in treating intrahepatic cholangiocarcinoma.

Autor: Andraus, Wellington, Ochoa, Gabriela, Bronze de Martino, Rodrigo, Nunes Pinheiro, Rafael Soares, Rocha Santos, Vinicius, Ducatti Lopes, Liliana, Macedo Arantes Júnior, Rubens, Reis Waisberg, Daniel, Chagas Santana, Alexandre, Tustumi, Francisco, Carneiro D'Albuquerque, Luiz Augusto

Publikováno v: Frontiers in Oncology; 2024, p1-8, 8p

Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers.

Autor: Connor, Ashton A., Kodali, Sudha, Abdelrahim, Maen, Javle, Milind M., Brombosz, Elizabeth W., Ghobrial, R. Mark

Publikováno v: Frontiers in Oncology; 11/21/2022, Vol. 12, p1-12, 12p

Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database.

Autor: Yao, Kaelan J.¹, Jabbour, Salma², Parekh, Niyati³, Yong Lin⁴, Moss, Rebecca A.⁵ mossr1@cinj.rutgers.edu

Publikováno v: BMC Gastroenterology. 9/21/2016, Vol. 16, p1-8. 8p. 1 Chart, 4 Graphs.

Regional variations in hepatocellular carcinoma incidence, routes to diagnosis, treatment and survival in England.

Autor: Burton A; HCC-UK/British Association for the Study of the Liver, Lichfield, UK.; National Cancer Registration and Analysis Service (NCRAS), Public Health England, London, UK., Balachandrakumar VK; National Cancer Registration and Analysis Service (NCRAS), Public Health England, London, UK.; Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK., Driver RJ; Leeds Institute for Medical Research at St. James's, University of Leeds, Leeds, UK., Tataru D; National Cancer Registration and Analysis Service (NCRAS), Public Health England, London, UK., Paley L; National Cancer Registration and Analysis Service (NCRAS), Public Health England, London, UK., Marshall A; Sheila Sherlock Liver Centre, The Royal Free Hospital, London, UK., Alexander G; Institute for Liver and Digestive Health, Royal Free Hospital Pond St, Hampstead, London, UK., Rowe IA; Leeds Institute for Medical Research at St. James's, University of Leeds, Leeds, UK., Palmer DH; Liverpool Experimental Cancer Medicine Centre, University of Liverpool, Liverpool, UK., Cross TJS; Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK. tim.cross@liverpoolft.nhs.uk.

Publikováno v: British journal of cancer [Br J Cancer] 2022 Mar; Vol. 126 (5), pp. 804-814. Date of Electronic Publication: 2021 Nov 26.